Objective : By observing the clinical efficacy of Modified Maxing Yigan Decoction in the treatment of cough variant asthma(damp-heat stagnant lung syndrome)in children,we initially evaluated its safety and efficacy and provided reference for the treatment of cough variant asthma in children with Chinese medicine.Method:Seventy-two children with cough variant asthma who attended the pediatric outpatient clinic of the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine from January 2022 to January 2023 and met the inclusion criteria of this study were selected as observation subjects and grouped according to the random number table method,including 36 cases in the test group,2 cases of shedding,and 34 cases of actual completion;36 cases in the control group,3 cases of shedding,and 33 cases of actual completion.The test group was given Modified Maxing Yigan Decoction and the control group was given montelukast sodium chewable tablets.After2 weeks of treatment,the changes in the symptom scores of the children in the two groups were compared before and after treatment to assess the differences in the efficacy of the drugs between the two groups.Results: 1.The differences between the two groups of children in terms of gender,age,disease duration and pre-treatment points of each symptom were not statistically significant and were comparable at P>0.05.2.The total effective rate of the test group was 91%,and the total effective rate of the control group was 75%,P<0.05,the difference was statistically significant,and the efficacy of the test group was better than that of the control group.3.The intra-group differences in primary and secondary symptoms and evidence points before and after treatment were compared between the two groups,and P<0.001,a highly significant difference,indicating that both groups were effective in treating this disease.4.The difference between the two groups in terms of main symptoms,secondary symptoms and symptom scores after treatment was compared,P<0.001,indicating that the test group was better than the control group in terms of main symptoms,secondary symptoms and symptom scores.5.In the treatment of this disease,the test group had better efficacy compared with the control group in terms of daytime cough,nighttime cough,itchy throat,stuffiness in the chest and epigastrium,poor appetite,drowsiness and sleepiness,short urine,sticky stool and tongue coating,etc.P<0.05,indicating that the test group had better efficacy in improving the above symptoms.Conclusions: 1.The treatment of cough variant asthma(damp-heat stagnant lung syndrome)in children with Modified Maxing Yigan Decoction has remarkable clinical effects.2.The therapeutic effect of Modified Maxing Yigan Decoction on children with cough variant asthma(damp-heat stagnant lung syndrome)is improvement in various aspects such as daytime cough,nighttime cough,itchy throat,stuffiness in the chest and epigastrium,poor appetite,drowsiness and fatigue,short urine,sticky stools and tongue coating,rather than focusing on one aspect.3.Modified Maxing Yigan Decoction had a significant advantage over the control group in improving the main symptoms,secondary symptoms and symptom scores of cough variant asthma(damp-heat stagnant lung evidence)in children.4.The treatment of cough variant asthma(damp-heat stagnant lung syndrome)in children with Modified Maxing Yigan Decoction can effectively reduce the recurrence rate of this disease. |